Outcome of Salpingectomy Alone for Ovarian Cancer Evaluated

Share this content:
Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer.
Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer.

Salpingectomy alone may be a risk management option for women at hereditary risk of ovarian cancer, according to a review published in Cancer Prevention Research.

Mary B. Daly, M.D., from the Fox Chase Cancer Center in Philadelphia, and colleagues discuss salpingectomy alone as an option for risk management for women at hereditary risk of ovarian cancer.

The researchers note that bilateral salpingo-oophorectomy has become the standard of care for risk reduction. 

Although the procedure significantly decreases the risks of incidence of and mortality from ovarian cancer, it also impacts quality of life and may have long-term health consequences. Recent advances indicate that the fallopian tube epithelium may be the origin of most high-grade serous cancers.

Understanding the role of the fallopian tube in these cancers has led to consideration of salpingectomy alone as an option for risk management, especially for premenopausal women.

RELATED: Breast, Ovarian Cancer Risk Varies with BRCA Mutation Location

For women undergoing benign gynecologic surgery, bilateral salpingectomy with ovarian retention may have a public health benefit.

"Although our view of epithelial ovarian cancer initiation has improved drastically with the understanding that carcinogenesis can begin in the fallopian tube epithelium, many knowledge gaps must be acknowledged when we consider moving forward for this new prevention strategy," the authors write.

Reference

  1. Daly, Mary B., et al. "Salpingectomy as a Means to Reduce Ovarian Cancer Risk." Cancer Prevention Research. doi: 10.1158/1940-6207.CAPR-14-0293. [epub ahead of print]. January 13, 2015.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters